Sutro Biopharma, Inc.STRONASDAQ
Loading
Interest Expense Over TimeExpanding
Percentile Rank100
3Y CAGR+127.5%
5Y CAGR+58.2%
Studio
Year-over-Year Change

Interest expense on outstanding debt

3Y CAGR
+127.5%/yr
vs +20.3%/yr prior
5Y CAGR
+58.2%/yr
Recent acceleration
Acceleration
+107.2pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
9.9x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$39.39M+26.8%
2024$31.07M+30.8%
2023$23.75M+609.8%
2022$3.35M+6.7%
2021$3.14M-21.1%
2020$3.97M-8.6%
2019$4.35M+171.9%
2018$1.60M+132.2%
2017$689000.00-
2016$0.00-